Navigation Links
Tackling Atrial Fibrillation and Associated Cardiovascular Risk
Date:11/4/2008

nd paste it into your browser)

2. Click "Register"

3. On the registration form, enter your information then click "Submit"

Once the host approves your registration, you will receive a confirmation email containing instructions on how to join the event (event number and password) on the day of the announcement.

Once logged on, you will also be required to connect to a teleconference in order to participate in the live Q&A session with panelists at the end of the event.

Teleconference dial in number (toll-free):

1) To obtain your teleconference number, register first by following the instructions above.

2) Once connected, a pop-up window will appear

3) Select country of affiliation to obtain local dial-in number

4) Dial-in and enter your login details using the provided number within the pop-up window

Please ensure you log on to the event 15 minutes before the start time so as not to miss valuable information.

IMPORTANT NOTICE:

This event is not part of the official Scientific Sessions 2008 as planned by the AHA Committee on Scientific Sessions Programming


'/>"/>
SOURCE Sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
2. Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
3. Further Analysis From ATHENA Study Showed That Multaq(R)(Dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation
4. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
5. American Heart Journals Publishes Results From ERATO Trial Showing Dronedarone (Multaq(R)) Improves Ventricular Rate Control in Patients With Permanent Atrial Fibrillation
6. Multaq(R) (dronedarone) Granted FDA Priority Review for Patients with Atrial Fibrillation
7. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
8. Landmark ATHENA Study Findings With Multaq(R) (dronedarone) Shows 24% Reduction In Cardiovascular Hospitalization or Death in Patients With Atrial Fibrillation
9. Circulation Publishes Data Showing KYNAPID(TM) (Vernakalant Hydrochloride) Injection Rapidly Converted Short-Duration Atrial Fibrillation to Sinus Rhythm
10. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
11. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... MELBOURNE, Australia , July 11, 2014  Australian ... today announced that it has raised A$19.3 million via ... Europe , the U.S., ... and A$3 million from a share purchase plan (SPP) ... A$16.3 million will be made in two tranches. ...
(Date:7/11/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/tjlw9k/immunoprotein ... "Immunoprotein Diagnostic Testing Market - Forecasts to 2019: ... 6% and is expected to be valued at ... http://photos.prnewswire.com/prnh/20130307/600769 ... been segmented according to immunoprotein types which include ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
Breaking Medicine Technology:Phosphagenics' A$19.3 million Capital Raising 2Phosphagenics' A$19.3 million Capital Raising 3Immunoprotein Diagnostic Testing Market - Forecasts to 2019: Expected to grow at the highest CAGR of 6% and is expected to be valued at USD 4,943.0 million 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
...  Millennium Laboratories announced today the Clinical Laboratory Responsibility ... responsible and ethical business practices in the medication ... which Millennium adheres and to which the company ... industry to adopt. (Logo: ...
... Inc., a critical care company focused on developing and commercializing ... Center for Devices and Radiological Health ... Administration (FDA) has granted 510(k) clearance for compatibility of its ... INOMAX DS and the INOMAX DSIR have now been validated ...
Cached Medicine Technology:Millennium Laboratories Announces Laboratory Responsibility Pledge 2Millennium Laboratories Announces Laboratory Responsibility Pledge 3FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems 2FDA Clears Expanded Compatibility for INOMAX® Drug-Delivery Systems 3
(Date:7/12/2014)... The report, "Phthalic Anhydride and Derivatives ... Application & Geography – Trends & Forecast to 2018," ... forecasting of market volume and value. The report also ... The market of phthalic anhydride is projected to grow ... million by 2018, with a CAGR of 5.24% from ...
(Date:7/12/2014)... The Security Analytics market is estimated to ... by 2019, at an expected CAGR of 9.7% for ... counter the increasing number of security breaches, continued line ... systems in organizations are enormous. Vendors in the security ... architecture to develop better and more secure systems. , ...
(Date:7/12/2014)... 12, 2014 (HealthDay News) -- Burn injuries increase in the ... grills, say burn experts. Among those most vulnerable to these ... most vulnerable and often get burned by putting their hands ... director of the burn unit at Loyola University Medical Center ... "The old adage of ,When you play with fire, you ...
(Date:7/12/2014)... 2014 As DePuy Pinnacle hip lawsuits ... courts, Bernstein Liebhard LLP notes the publication of a ... the failure of metal-on-metal hip replacements. The research, which ... of Bone & Joint Surgery, looked at 597 ... prostheses at least twelve months earlier. The blood metal ...
(Date:7/12/2014)... Doylestown Hospital recently conducted an interview with ... questions. Paddock tackles topics including main men's health ... longer than men, and testosterone replacement therapy, among others. ... featured on Doylestown Hospital’s website, Dr. Brad Paddock says, ... If you notice pain, bulging, or asymmetry in your ...
Breaking Medicine News(10 mins):Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 2Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 3Health News:North America Security Analytics Market Worth $1,215.2 Million by 2019 - New Report by MicroMarket Monitor 4Health News:Burn Injuries More Common in Summer 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 3Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Release of New Study Tying Elevated Metal Ions to Metal-on-Metal Hip Failure 4Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
... deficiencies in healthcare provision in parts of Mecklenburg-West Pomerania. ... Greifswald University and her coauthors in the current edition ... 2010; 107[18]: 328-34). They emphasize that similar trends can ... The demographic transition leads to an increase in the ...
... ... prevention of a wide range of both common and rare diseases are possible before ... ... new Existence! Existence Genetics LLC, the world’s first predictive medicine company, is ...
... ... continues to challenge scientists. There is growing evidence that increases in protease ... team of scientists at the University of Alabama measured a common protease ... with healthy volunteers. Previous studies have shown increases in MMP-9 in CF ...
... ... Citrix and Insight Venture Partners , ... Philadelphia, PA (Vocus) May 20, 2010 -- PHD Virtual Technologies , pioneer and ... investment agreement with Citrix Systems, a leading provider of virtual computing solutions that help companies ...
... rosemary, turmeric, fingerroot inhibited production of carcinogenic compounds , ... certain spices to your burgers before tossing them on ... the flavor of the meat, but they can also ... cooking of beef. , Scientists at Kansas State University ...
... ... NanaWall Systems, Inc. announces the NanaWall SL60 is featured in the ... sponsored by the USGBC for interior designers to showcase the best ... The NanaWall connects the hotel suite to an outdoor lounge ...
Cached Medicine News:Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 2Health News:Existence Genetics is Pioneering the Field of Predictive Medicine - Nexus Technologies Critical in Understanding and Preventing Deadly Disease 3Health News:News from Molecular Medicine 2Health News:PHD Virtual Technologies Announces Citrix Investment 2Health News:PHD Virtual Technologies Announces Citrix Investment 3Health News:PHD Virtual Technologies Announces Citrix Investment 4Health News:Some Spices Cut Cancer Risk That Comes With Grilled Burgers 2Health News:NanaWall Featured in Award-winning Green Hotel Suite 2Health News:NanaWall Featured in Award-winning Green Hotel Suite 3
... Hand-Held Pulse Oximeter provides SpO 2 and ... adult. The device is battery or AC ... visible and audible alarm signals, and an infrared ... rubber boot is also available for added protection. ...
... Hand-Held Pulse Oximeter with built-in Summary ... screening studies in the sleep lab, ... its easy-to-use, 2-key operation, it also ... SpO 2 , pulse rate and ...
... is a cost-effective, stand-alone monitor that delivers ... and pulse strength measurements of patients from ... battery powered unit displays a plethysmographic waveform, ... to 30 hours of on screen trended ...
... Administration (FDA) has granted approval of Alcon's ... patients with and without presbyopia. This innovative ... to give patients a full range of ... greatly increases their independence from glasses after ...
Medicine Products: